Symphony Financial’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$312K Buy
3,893
+939
+32% +$75.7K 0.03% 254
2026
Q1
$253K Sell
2,954
-1,051
-26% -$101K 0.03% 266
2025
Q4
$386K Sell
4,005
-143
-3% -$13.9K 0.05% 193
2025
Q3
$393K Buy
4,148
+2,641
+175% +$243K 0.05% 187
2025
Q2
$228K Buy
+1,507
New +$128K 0.03% 234

Other funds holding MDT

Symphony Financial's MDT Position: Q2 2026 in Review

Symphony Financial increased its Medtronic (MDT) stake by 32% in Q2 2026, buying an estimated $75.7K and bringing the position to 3,893 shares worth $312K. The position accounts for 0.03% of the portfolio, ranked #254.

Symphony Financial first reported a position in MDT in Q2 2025 and has held it in 5 quarters since. The position peaked at $393K in Q3 2025. 1,806 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Symphony Financial held 3,893 shares of Medtronic worth $312K as of Q2 2026.
  • Symphony Financial bought 939 Medtronic shares in Q2 2026, an estimated $75.7K.
  • Medtronic made up 0.03% of Symphony Financial's portfolio in Q2 2026, its #254 holding.
  • Symphony Financial first reported a position in Medtronic in Q2 2025 and has held it in 5 quarters since.
  • Symphony Financial's Medtronic position peaked at $393K in Q3 2025.
  • 1,806 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Symphony Financial's 13F filing for Q2 2026, filed 4 Aug 2026.